The U.S. Department of Veterans Affairs (VA) awarded a $130.7 million Indefinite Delivery Contract (IDC) to Foundation Medicine, Inc., a leading provider of genomic profiling and molecular analysis services, for specialized tumor molecular profiling services. This single-award IDC, with a completion date of September 12, 2029, aims to provide the VA's National Precision Oncology Program with comprehensive genomic profiling for both solid and hematological malignancies. The contracted services include next-generation sequencing (NGS) panels, NGS comprehensive genomic profiling (CGP), and complementary tests such as immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) to support precision oncology initiatives for veterans.
Under this IDC, Foundation Medicine is required to have the capability to analyze a minimum of 5,000 tumor samples annually and provide associated genomic reports to aid in clinical decision-making for oncology patients across VA medical centers nationwide. The contract is not set aside and was awarded based on a best value trade-off evaluation, with non-price factors, such as technical approach and past performance, being significantly more important than price. This IDC award demonstrates the VA's commitment to leveraging Foundation Medicine's expertise in genomic profiling to advance precision medicine for the veteran population.
Generated 3/6/25, 10:01 AM